Physiology of migraine involving renin-angiotensin systems (RAS) has been implicated. Ramipril is a broadly-used angiotensin-converting enzyme inhibitor. The investigators attempt to test the efficacy of ramipril on the prophylaxis of migraine attacks.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
ramipril 2.5mg twice a day
Seoul National University Hospital
Seoul, South Korea
headache frequency
headache days
Time frame: 12 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.